Back

Impact of reasons for discontinuing anticoagulation therapy on clinical outcomes in patients with venous thromboembolism: insight from the COMMAND VTE Registry-2

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Venous thromboembolism Venous Thromboembolism ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Makoto Kinugawa

Toyonaka Municipal Hospital, Toyonaka (Japan)

7 More presentations in this session

Presentation thumbnail
Statin therapy for the prevention of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Doctor F. Catalani (Bellinzona, CH)
Abstract Slides Video
Presentation thumbnail
Impact of thrombocytopenia on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT Study
Doctor Y. Miyoshi (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
The predictive value of estimated glucose disposal rate for the risk of venous thromboembolism in elderly individuals: a prospective cohort study of UK biobank
Doctor Y. Zheng (Tianjin, CN) Doctor T. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Comparison of hospital and home treatment for symptomatic proximal deep vein thrombosis: from theCOMMAND VTE Registry-2
Mr K. Mushiake (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Has post-COVID-19 increased CTEPD rates? A prospective study on persistent dyspnea and risk factors
Doctor L. Alajbegovic (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Venous thromboembolism

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
From bench to bedside: how changes in the data landscape have shaped venous thromboembolism treatment as well as prevention of recurrence
thumbnail
Congress Presentation
Discussant review - HI-PRO
thumbnail
Congress Session
Evolution of anticoagulation therapy in patients with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources